|
Recent clinical trials have shed new light on treatments for COVID-19, but a growing list of retractions of COVID-19 papers have also sparked concerns about data quality and “science by press release.†To weigh in on these developments, CMAJ reached out to infectious disease specialists Dr. Srinivas Murthy of B.C. Children’s Hospital and the University of British Columbia in Vancouver, Dr. Matthew Oughton of Jewish General Hospital and McGill University in Montreal, and Dr. Alon Vaisman of the University Health Network in Toronto.
|